Charles Mordaunt is a computational biologist with a decade of experience translating genomic and epigenomic data into actionable target insights, currently advancing human genetics at GSK. He combines hands-on analyses of GWAS, bulk and single-cell RNA-seq, and epigenomic datasets with database construction and benchmarking to improve variant-to-gene mapping and prioritize therapeutic targets. His academic work at UC Davis leveraged whole-genome bisulfite sequencing and systems-biology approaches to uncover methylation signatures in autism and Wilson disease, and he has developed tools and pipelines for DMR identification and visualization. Based in Philadelphia, he brings a rare blend of rigorous wet-lab–informed genomics and production-focused bioinformatics that helps bridge discovery and translational genetics.
10 years of coding experience
9 years of employment as a software developer
Doctor of Philosophy (Ph.D.) Biochemistry Molecular Cellular and Developmental Biology, Doctor of Philosophy (Ph.D.) Biochemistry Molecular Cellular and Developmental Biology at University of California, Davis
B.S. Molecular Biology and Biotechnology Minor in Chemistry, B.S. Molecular Biology and Biotechnology Minor in Chemistry at California State University, Fullerton
Contributions:45 commits, 43 pushes, 1 branch in 1 year 2 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.